<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03153995</url>
  </required_header>
  <id_info>
    <org_study_id>FDASU-REC per-16-3</org_study_id>
    <nct_id>NCT03153995</nct_id>
  </id_info>
  <brief_title>Alveolar Ridge Augmentation Following Self-Inflating Soft Tissue Expander</brief_title>
  <official_title>Alveolar Ridge Augmentation Following Self-Inflating Soft Tissue Expander: A Randomized Controlled Clinical and Histological Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study will be to assess and compare between sub-periosteal self-&#xD;
      inflating osmotic tissue expanders used as preparatory surgery before alveolar ridge&#xD;
      augmentation and periosteal releasing incision using autogenous onlay block bone graft.&#xD;
&#xD;
      The assessment and comparison will be based on:&#xD;
&#xD;
        1. Change in edentulous alveolar ridge in bucco-lingual dimension after alveolar&#xD;
&#xD;
           ridge augmentation.&#xD;
&#xD;
        2. Quantity of the soft tissue obtained after soft tissue expansion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Sixteen patients will be selected from the outpatient clinic of the department of, Oral&#xD;
           medicine Periodontology, and oral diagnosis, Faculty of Dentistry, Ain Shams University.&#xD;
&#xD;
        -  Three surgeries will be carried out for group I patient; the first is placement of soft&#xD;
           tissue expander, the second surgery is bone grafting and placement of collagen membrane&#xD;
           for ridge augmentation while the third (re-entry surgery) is implant placement in a&#xD;
           routine fashion.&#xD;
&#xD;
      two surgeries will be carried out for group II patient; the first is surgery is bone grafting&#xD;
      for ridge augmentation while the second (re-entry surgery) is implant placement in a routine&#xD;
      fashion.&#xD;
&#xD;
      -Measurements and evaluation of edentulous ridge will be done by CBCT&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Actual">November 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ridge dimensional alteration by CBCT</measure>
    <time_frame>baseline, 6 months after surgery, 3 months after implant surgery</time_frame>
    <description>The ridge width will be compared between the two treatment groups by CBCT</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Soft tissue volume gain</measure>
    <time_frame>baseline, 4 weeks</time_frame>
    <description>Soft tissue volume gain will be assessed by volumetric analysis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Horizontal Ridge Deficiency</condition>
  <arm_group>
    <arm_group_label>sub-periosteal soft tissue expansion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eight patients will receive osmotic hydrogel expanders prior to bone augmentation procedures. All expanders will be placed in sub-periosteal positions using the tunnel technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>periosteal releasing incision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>periosteal releasing incision will be performed for Eight patients during ridge augmentation surgery .</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>soft tissue expansion</intervention_name>
    <description>Three surgeries will be carried out for group I patients:&#xD;
Soft tissue expansion (1st surgery); at baseline&#xD;
Alveolar ridge augmentation (2nd surgery); after five weeks&#xD;
Implant surgery (3rd surgery); after six months</description>
    <arm_group_label>periosteal releasing incision</arm_group_label>
    <arm_group_label>sub-periosteal soft tissue expansion</arm_group_label>
    <other_name>osmed</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients should have partially edentulous ridge (missing upper one or two&#xD;
             neighboring anterior teeth or premolars) of the maxilla. The edentulous area should&#xD;
             require horizontal bone augmentation procedures owing to lack of sufficient residual&#xD;
             bone.&#xD;
&#xD;
          -  All patients should not have any particular medical history (medically free) according&#xD;
             to Burket health medical history questionnaire (Glick et al.2008).&#xD;
&#xD;
          -  All patients should not have any known contraindication to oral surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers will be excluded from our study.&#xD;
&#xD;
          -  Patients with poor oral hygiene or not willing to perform oral hygiene measures.&#xD;
&#xD;
          -  Patients who showed residual infections in the edentulous area or apparent infection&#xD;
             in a neighboring tooth.&#xD;
&#xD;
          -  Patients with systemic diseases such as diabetes mellitus and hemorrhagic disorders,&#xD;
             patients receiving intravenous bisphosphonate therapy or systemic corticosteroid&#xD;
             treatment.&#xD;
&#xD;
          -  Patients with occlusal discrepancies will be excluded.&#xD;
&#xD;
          -  Vulnerable groups (as pregnant and lactating females, and decisionaly impaired&#xD;
             individuals) will be excluded from the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed Amr, lecturer</last_name>
    <role>Study Director</role>
    <affiliation>Ainshams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nevine Kheir eldin, professor</last_name>
    <role>Study Director</role>
    <affiliation>Ainshams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ehab Abd elhamid, professor</last_name>
    <role>Study Director</role>
    <affiliation>Ainshams University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of dentistry Ain Shams university</name>
      <address>
        <city>Cairo</city>
        <state>Cairo Governorate</state>
        <zip>11553</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 4, 2017</study_first_submitted>
  <study_first_submitted_qc>May 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2017</study_first_posted>
  <last_update_submitted>November 27, 2020</last_update_submitted>
  <last_update_submitted_qc>November 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Alaa Talaat Ali</investigator_full_name>
    <investigator_title>assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>expander</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

